Korean Circulation Journal

  • 제41권11호
  • /
  • Pages.677-680
  • /
  • 2011
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis

  • Hachinohe, Daisuke (The Heart Center of Sapporo Higashi Tokushukai Hospital) ;
  • Jeong, Myung-Ho (The Heart Center of Chonnam National University Hospital) ;
  • Kim, Min-Chol (The Heart Center of Chonnam National University Hospital) ;
  • Cho, Kyung-Hoon (The Heart Center of Chonnam National University Hospital) ;
  • Ahmed, Khurshid (The Heart Center of Chonnam National University Hospital) ;
  • Hwnag, Seung-Hwan (The Heart Center of Chonnam National University Hospital) ;
  • Lee, Min-Goo (The Heart Center of Chonnam National University Hospital) ;
  • Sim, Doo-Sun (The Heart Center of Chonnam National University Hospital) ;
  • Park, Keun-Ho (The Heart Center of Chonnam National University Hospital) ;
  • Kim, Ju-Han (The Heart Center of Chonnam National University Hospital) ;
  • Hong, Young-Joon (The Heart Center of Chonnam National University Hospital) ;
  • Ahn, Young-Keun (The Heart Center of Chonnam National University Hospital) ;
  • Kang, Jung-Chaee (The Heart Center of Chonnam National University Hospital)
  • 발행 : 2011.11.30
⟨ 이전 논문 다음 논문 ⟩

초록

A 51-year-old man was admitted due to an acute anterior ST-segment elevation myocardial infarction. After thrombolytic therapy using recombinant tissue plasminogen activator, stent implantation was performed from the proximal left anterior descending artery (LAD) to the mid LAD using a bare-metal stent (BMS). Since then, the patient suffered five repeated episodes of in-stent restenosis (ISR). At the first ISR, he was treated with plain old balloon angioplasty (POBA). At the second ISR, he was treated with brachytherapy, and at the third ISR, he was treated with POBA and one more BMS distal to the previously implanted stent. At the forth, only POBA was performed, and finally, at the fifth ISR, a sirolimus-eluting stent was implanted. Following that, the patient remained asymptomatic and follow-up coronary angiography showed no ISR.

키워드

참고문헌

  1. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-95. https://doi.org/10.1056/NEJM199408253310801
  2. Ahmed JM, Mintz GS, Weissman NJ, et al. Mechanism of lumen enlargement during intracoronary stent implantation: an intravascular ultrasound study. Circulation 2000;102:7-10. https://doi.org/10.1161/01.CIR.102.1.7
  3. Chen MS, John JM, Chew DP, Lee DS, Ellis SG, Bhatt DL. Bare metal stent restenosis is not a benign clinical entity. Am Heart J 2006;151: 1260-4. https://doi.org/10.1016/j.ahj.2005.08.011
  4. Stone GW, Ellis SG, Colombo A, et al. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation. Circulation 2007;115:2842-7. https://doi.org/10.1161/CIRCULATIONAHA.106.687186
  5. Waksman R, Bhargava B, White L, et al. Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation 2000;101: 1895-8. https://doi.org/10.1161/01.CIR.101.16.1895
  6. Popma JJ, Suntharalingam M, Lansky AJ, et al. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation 2002;106:1090-6. https://doi.org/10.1161/01.CIR.0000027814.96651.72
  7. Stone GW, Ellis SG, O'Shaughnessy CD, et al. Paclitaxel-eluting st-ents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 2006;295:1253-63. https://doi.org/10.1001/jama.295.11.1253
  8. Alfonso F, Pérez-Vizcayno MJ, Hernandez R, et al. A randomized com-parison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the restenosis intrastent: balloon angioplasty versus elective sirolimus-eluting stenting (RIBS-II) trial. J Am Coll Cardiol 2006;47:2152-60. https://doi.org/10.1016/j.jacc.2005.10.078
  9. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994;331:496-501. https://doi.org/10.1056/NEJM199408253310802
  10. Kastrati A, Mehilli J, Dirschinger J, et al. Restenosis after coronary placement of various stent types. Am J Cardiol 2001;87:34-9.
  11. Schuhlen H, Kastrati A, Mehilli J, et al. Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement. Am Heart J 2004;147:317-22. https://doi.org/10.1016/j.ahj.2003.10.002
  12. Radke PW, Kaiser A, Frost C, Sigwart U. Outcome after treatment of coronary in-stent restenosis; results from a systematic review using meta-analysis techniques. Eur Heart J 2003;24:266-73.
  13. Hong YJ, Jeong MH. New methods of vascular brachytherapy for co-ronary stent restenosis. Korean Circ J 2003;33:967-76.
  14. Kim SH, Kim MH, Cha KS, et al. Effect of vascular brachytherapy us-ing HolmiuM-166 liquid balloon system after cutting balloon angioplasty in patients with stent restenosis (BRAHMS Study). Korean Circ J 2005;35:591-6. https://doi.org/10.4070/kcj.2005.35.8.591
  15. Kastrati A, Mehilli J, von Beckerath N, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 2005;293:165-71. https://doi.org/10.1001/jama.293.2.165